Firmonertinib in the Treatment of EGFR(+) NSCLC Patients With Central Nervous System Metastasis

Clinical trial NCT07239102 · COMPLETED

Trial details

NCT number: NCT07239102
Sponsor: Beijing Tiantan Hospital
Status: COMPLETED
Study type: OBSERVATIONAL

EGFR Positive Non-small Cell Lung Cancer Central Nervous System Metastasis Leptomeningeal Metastasis

Start date: 2020-01-01
Primary completion: 2025-05-01
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.